NCT05479461 Technology-enabled Management Versus Usual Care for Blood Pressure
| NCT ID | NCT05479461 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Stanford University |
| Condition | Hypertension |
| Study Type | INTERVENTIONAL |
| Enrollment | 200 participants |
| Start Date | 2023-06-13 |
| Primary Completion | 2025-09-15 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 200 participants in total. It began in 2023-06-13 with a primary completion date of 2025-09-15.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Two arm parallel randomized clinical trial
Eligibility Criteria
Inclusion Criteria: * Age 30-90 yrs. * Smartphone ownership * Office SBP: ≥ 140 mm Hg * ≤ 2 current anti-HTN meds * Able to add or dose-increase at least 2 of the following classes of medications: ACE-I/ARB, diuretic, calcium channel blocker, beta-blocker, mineralocorticoid receptor antagonists (i.e., at least 2 classes are available for addition or dose- increases after excluding intolerant medications and medications currently at maximum dose) * English or Spanish-speakers Exclusion Criteria: * Heart failure with reduced ejection fraction (EF \< 40%) * ESRD (GFR \<15) * Renal replacement therapy * Pregnant * Myocardial infarction or stroke within preceding 6 months * Hospitalization for hypertensive emergency or malignant hypertension within preceding 6 months * Prior solid organ transplantation * At the clinical discretion of the investigators * Enrolled in another clinical study
Contact & Investigator
Paul J Wang, MD
PRINCIPAL INVESTIGATOR
Stanford University
Frequently Asked Questions
Who can join the NCT05479461 clinical trial?
This trial is open to participants of all sexes, aged 30 Years or older, up to 90 Years, studying Hypertension. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05479461 currently recruiting?
Yes, NCT05479461 is actively recruiting participants. Contact the research team at pjwang@stanford.edu for enrollment information.
Where is the NCT05479461 trial being conducted?
This trial is being conducted at Palo Alto, United States, Atlanta, United States, Eatonton, United States.
Who is sponsoring the NCT05479461 clinical trial?
NCT05479461 is sponsored by Stanford University. The principal investigator is Paul J Wang, MD at Stanford University. The trial plans to enroll 200 participants.